Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 301 | 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY//LEVOSIMENDAN//PHARMACOLOGY & PHARMACY | 41522 |
| 1503 | 2 | NEBIVOLOL//CARVEDILOL//BETA BLOCKERS | 7786 |
| 26393 | 1 | MED HOSP PHARM YAHATANISHI KU//PROPRANOLOL METABOLITE//4 HYDROXYPROPRANOLOL | 277 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | MED HOSP PHARM YAHATANISHI KU | address | 409599 | 2% | 60% | 6 |
| 2 | PROPRANOLOL METABOLITE | authKW | 227558 | 1% | 100% | 2 |
| 3 | 4 HYDROXYPROPRANOLOL | authKW | 165491 | 1% | 36% | 4 |
| 4 | 2 X 2 CROSS OVER STUDY | authKW | 113779 | 0% | 100% | 1 |
| 5 | 3 HYDROXYPROPRANOLOL | authKW | 113779 | 0% | 100% | 1 |
| 6 | ACETYL CONJUGATE | authKW | 113779 | 0% | 100% | 1 |
| 7 | ACETYLTRANSFARASE AT | authKW | 113779 | 0% | 100% | 1 |
| 8 | ALDEHYDE INTERMEDIATE | authKW | 113779 | 0% | 100% | 1 |
| 9 | ALTERED ENZYME HYPOTHESIS | authKW | 113779 | 0% | 100% | 1 |
| 10 | BETA ADRENOCEPTOR ANTAGONISTIC ACTION | authKW | 113779 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 5368 | 79% | 0% | 219 |
| 2 | Chemistry, Medicinal | 307 | 10% | 0% | 29 |
| 3 | Toxicology | 217 | 9% | 0% | 25 |
| 4 | Chemistry, Multidisciplinary | 26 | 9% | 0% | 26 |
| 5 | Chemistry, Analytical | 11 | 4% | 0% | 12 |
| 6 | Pathology | 8 | 2% | 0% | 6 |
| 7 | Biochemical Research Methods | 6 | 3% | 0% | 7 |
| 8 | Spectroscopy | 5 | 2% | 0% | 5 |
| 9 | Medical Laboratory Technology | 2 | 1% | 0% | 2 |
| 10 | Critical Care Medicine | 1 | 1% | 0% | 2 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | MED HOSP PHARM YAHATANISHI KU | 409599 | 2% | 60% | 6 |
| 2 | GERIAT PHARMACOL THER EUT | 113779 | 0% | 100% | 1 |
| 3 | ID CEDD DMPK | 113779 | 0% | 100% | 1 |
| 4 | MED PHARM YAHATANISHI KU | 113779 | 0% | 100% | 1 |
| 5 | PHARMACEUT SCI HIGASHIMURACHO | 113779 | 0% | 100% | 1 |
| 6 | FATC 7355 | 56888 | 0% | 50% | 1 |
| 7 | NEUROPHYSIOL NEUROTOXICOL UNIT | 56888 | 0% | 50% | 1 |
| 8 | ADV ANALYT DEV | 37925 | 0% | 33% | 1 |
| 9 | ENVIRONM VET MED SCI | 18961 | 0% | 17% | 1 |
| 10 | MED HIGASHI KU | 18961 | 0% | 17% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | DRUG METABOLISM AND DISPOSITION | 18369 | 13% | 0% | 35 |
| 2 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 9296 | 8% | 0% | 22 |
| 3 | DRUG-NUTRIENT INTERACTIONS | 5685 | 1% | 3% | 2 |
| 4 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 5561 | 2% | 1% | 6 |
| 5 | BIOPHARMACEUTICS & DRUG DISPOSITION | 2858 | 3% | 0% | 7 |
| 6 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2694 | 5% | 0% | 14 |
| 7 | RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY | 1781 | 2% | 0% | 6 |
| 8 | JOURNAL OF PHARMACEUTICAL SCIENCES | 1428 | 4% | 0% | 12 |
| 9 | BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY | 1403 | 1% | 0% | 3 |
| 10 | BIOCHEMICAL PHARMACOLOGY | 1357 | 5% | 0% | 15 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |